Software systems known as neural networks are at the heart of artificial intelligence and are becoming more and more part of our daily life. These networks are used to translate languages, classify images, and recognize diseases, among many other applications. Deep-learning algorithms require a substantial amount of computer resources, but can nevertheless be executed by conventional computers, built around the classical von Neumann architecture. However, the simulation of these networks on classical systems turns out to be extremely inefficient. Brain-inspired (neuromorphic) computing aims to mimic the efficiency of the brain in such A.I. applications and has recently demonstrated advancements in pattern and image recognition. However, conventional neuromorphic devices and systems suffer from instability, unpredictability, and often substantial energy use, complicating the path to achieve the interconnectivity and efficiency of the brain.
In this project we use a low-cost solution organic artificial synapse as a building-block for these smart systems. The conductance of this single synapse can be accurately tuned by controlled ion injection in the conductive polymer which allows for straightforward low-energy analogue computing. BIOMORPHIC is building an interconnected network of these synapses to obtain a true neuromorphic array. The goal is to develop a unique brain-inspired organic lab-on-a-chip in which microfluidics integrated with sensors, collecting characteristics of biological cells, will serve as input to the neuromorphic array. BIOMORPHIC will combine modular microfluidics and machine-learning to develop a novel platform for low-cost lab-on-a-chip devices capable of on-chip classification. Ultimately the project aims to classify circulating tumour cells on the chip using a multitude of sensor signals trained to recognize these cells.
The project was very successful and includes a number of breakthroughs. We were the first to demonstrate on chip classification of biosignals using organic neuromorphic hardware. We have also shown adaptive biosensing using novel materials. Although we were not able to demonstrate on-chip cancer cell classification, our results do provide a major step towards integrated neuromorphic hardware for healthcare and biosignals classification.